Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1647-1651

  Bray, Michael ^a   Men, Ruhe ^a   Tokimatsu, Issei ^a   Lai, Ching Juh ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CHIMERA; CONTROLLED STUDY; DENGUE VIRUS; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS VIRULENCE;

EID: 0031883267     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1647-1651.1998     Document Type: Article

References (34)

1. Bhamarapravati, N., S. Yoksan, T. Chayaniyayothin, S. Angsubphakorn, and A. Bunyaratvej. 1987. Immunization with a live attenuated dengue-2 virus candidate vaccine (16681-PDK53): clinical, immunological and biological responses in adult volunteers. Bull. W. H. O. 65:189-195.
2. Blok, J., M. McWilliam, H. C. Butler, A. J. Gibbs, G. Weiller, B. L. Herring, A. G. Hemsley, J. G. Aaskov, S. Yoksan, and N. Bhamarapravati. 1992. Comparison of a dengue-2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 187: 573-590.
3. Bray, M., and C. J. Lai. 1991. Dengue virus pre-membrane and membrane proteins elicit a protective immune response. Virology 185:505-508.
4. Bray, M., and C. J. Lai. 1991. Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc. Natl. Acad. Sci. USA 88:10342-10346.
5. Bray, M., and C. J. Lai. 1992. Construction and characterization of chimeric dengue viruses, p. 271-276. In F. Brown, R. M. Chanock, H. S. Ginsberg, and R. A. Lerner (ed.), Vaccine 92. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
6. Bray, M., B. Zhao, L. Markoff, K. H. Eckels, R. M. Chanock, and C. J. Lai. 1989. Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis. J. Virol. 63:2853-2856.
7. Chen, W., H. Kawano, R. Men, and D. Clark, and C. J. Lai. 1995. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J. Virol. 69:5186-5190.
8. Edelman, R., C. O. Tacket, S. S. Wasserman, D. W. Vaughn, K. H. Eckels, D. R. Dubois, P. L. Summers, and C. H. Hoke. 1994. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J. Infect. Dis. 170:1448-1455.
9. Falgout, B., M., Bray, J. J. Schlesinger, and C. J. Lai. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J. Virol. 64:4356-4363.
10. Guirakhoo, F., F. X. Heinz, C. W. Mandl, H. Holzmann, and C. Kunz. 1991. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72:1323-1329.
11. Heinz, F. X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
12. Heinz, F. X., K. Stiasny, G. Pueschner-Auer, H. Holzmann, S. Allison, C. W. Mandl, and C. Kunz. 1994. Structural change and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198:109-117.
13. Henchal, E. A., L. S. Henchal, and B. K. Thaisomboonsuk. 1987. Topological mapping of unique epitopes on the dengue-2 virus NS1 protein using monoclonal antibodies. J. Gen. Virol. 68:845-851.
14. Henchal, E. A., and J. R. Putnak. 1990. The dengue viruses. Clin. Microbiol. Rev. 3:376-396.
15. Hiramatsu, K., R. Men, and C. J. Lai. 1997. Unpublished observations.
16. Hotta, S. 1952. Experimental studies on dengue. I. Isolation, identification, and modification of the virus. J. Infect. Dis. 90:1-9.
17. Irie, K., P. M. Mochan, Y. Sagaguri, R. Putnak, and R. Padmanabhan. 1989. Sequence analysis of cloned dengue virus type 2 genome (New Guinea C strain). Gene 75:197-211.
18. Kawano, H., V. Rostapshov, L. Rosen, and C. J. Lai. 1993. Genetic determinants of dengue type 4 virus neurovirulence for mice. J. Virol. 67:6567-6575.
19. Kinney, R. M., S. Butrapel, G. J. Chang, K. R. Tsuchiya, J. T. Roehrig, N. Bhamarapravati, and D. J. Gubler. 1997. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230:300-308.
20. Lai, C. J., B. Zhao, H. Hori, and M. Bray. 1991. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc. Natl. Acad. Sci. USA 88:5139-5143.
21. Lee, E., R. C. Weir, and L. Dalgarno. 1997. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 232:281-290.
22. Mackenzie, J. M., M. J. Jones, and P. R. Young. 1996. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220:232-240.
23. Monath, T. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA 91:2395-2400.
24. Muylaert, I. R., R. Galler, and C. Rice. 1996. Mutagenesis of the N-glycosylation sites of the yellow fever virus NS1 protein: effects on RNA replication and mouse neurovirulence. Virology 222:159-168.
25. Puri, B., W. M. Nelson, E. A. Henchal, C. H. Hoke, K. H. Eckels, D. R. Dubois, K. R. Porter, and C. G. Hayes. 1997. Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells. J. Gen. Virol. 78:2287-2291.
26. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298.
27. Sabin, A. B., and R. W. Schlesinger. 1945. Production of immunity to dengue with virus modified by propagation in mice. Science 101:640-642.
28. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hvg. 1:30-50.
29. Sabin, A. B. 1955. Recent advances in our knowledge of dengue and sandfly fever. Am. J. Trop. Med. Hyg. 4:198-207.
30. Schlesinger, J. J., M. W. Brandriss, and E. E. Walsh. 1985. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 135:2805-2809.
31. Shapiro, D., W. E. Brandt, and P. K. Russell. 1972. Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology 50:906-911.
32. Stadler, K., S. L. Allison, J. Schalich, and F. X. Heinz. 1997. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71:8475-8481.
33. Stiasny, K., S. L. Allison, A. Marchler-Bauer, C. Kunz, and F. X. Heinz. 1996. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70:8142-8147.
34. Wisseman, C. L., Jr., B. H. Sweet, E. C. Rosenzweig, and O. R. Eylar. 1963. Attenuated living type 1 dengue vaccines. Am. J. Trop. Med. Hyg. 12:620-623.